Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03790982
What this trial is testing

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Zhejiang Hisun Pharmaceutical Co. Ltd. 240
Large-scale testing (Phase 3)Study completedNCT02017340
What this trial is testing

A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Prof Brian Lawlor 511
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Post-approval studies (Phase 4)Study completedNCT00988117
What this trial is testing

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Who this might be right for
Parkinsons Disease With DementiaParkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
University of California, San Francisco 15
Not applicableStudy completedNCT05860127
What this trial is testing

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Who this might be right for
DementiaCognitive Impairment, MildDementia, Vascular+6 more
University of Massachusetts, Amherst 133
Testing effectiveness (Phase 2)Study completedNCT00141661
What this trial is testing

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Who this might be right for
Alzheimer Disease
Pfizer 67
Post-approval studies (Phase 4)Study completedNCT00202124
What this trial is testing

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Queen's University 12
Not applicableLooking for participantsNCT07625241
What this trial is testing

CST+MST Intervention on People Living With Mild-to-moderate Dementia

Who this might be right for
Dementia
Istituto Superiore di Sanità 421
Not applicableUnknownNCT04495686
What this trial is testing

An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury

Who this might be right for
Dementia, MixedDementia MildDementia Moderate+2 more
University of Virginia 171
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Testing effectiveness (Phase 2)Study completedNCT00093951
What this trial is testing

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Saegis Pharmaceuticals 280
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)UnknownNCT05578443
What this trial is testing

Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fujian Medical University Union Hospital 66
Large-scale testing (Phase 3)Ended earlyNCT00857649
What this trial is testing

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 369
Large-scale testing (Phase 3)Looking for participantsNCT04570085
What this trial is testing

Effect of CAFfeine on Cognition in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University Hospital, Lille 248
Not applicableTemporarily pausedNCT03484143
What this trial is testing

Neuro RX Gamma - Pivotal Phase

Who this might be right for
Alzheimer Disease
Vielight Inc. 228
Not applicableStudy completedNCT05353049
What this trial is testing

How to Bathe a Person With Dementia? A Bathing Intervention Based on Basale Stimulation® for People With Moderate to Severe Dementia

Who this might be right for
Patient EngagementBehavioral Symptoms
University of Salamanca 50
Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Study completedNCT01723826
What this trial is testing

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 360
Next Page